408 related articles for article (PubMed ID: 32790577)
1. Molecular Physiology of Bile Acid Signaling in Health, Disease, and Aging.
Perino A; Demagny H; Velazquez-Villegas L; Schoonjans K
Physiol Rev; 2021 Apr; 101(2):683-731. PubMed ID: 32790577
[TBL] [Abstract][Full Text] [Related]
2. Bile Acids, Their Receptors, and the Gut Microbiota.
Poland JC; Flynn CR
Physiology (Bethesda); 2021 Jul; 36(4):235-245. PubMed ID: 34159805
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5.
Trammell SAJ; Svenningsen JS; Holst JJ; Gillum MP; Kuhre RE
Molecules; 2020 May; 25(10):. PubMed ID: 32443832
[TBL] [Abstract][Full Text] [Related]
4. Gut permeability, its interaction with gut microflora and effects on metabolic health are mediated by the lymphatics system, liver and bile acid.
Tran CD; Grice DM; Wade B; Kerr CA; Bauer DC; Li D; Hannan GN
Future Microbiol; 2015; 10(8):1339-53. PubMed ID: 26234760
[TBL] [Abstract][Full Text] [Related]
5. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
6. Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity.
Biagioli M; Carino A
Handb Exp Pharmacol; 2019; 256():95-108. PubMed ID: 31119464
[TBL] [Abstract][Full Text] [Related]
7. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice.
Zheng X; Huang F; Zhao A; Lei S; Zhang Y; Xie G; Chen T; Qu C; Rajani C; Dong B; Li D; Jia W
BMC Biol; 2017 Dec; 15(1):120. PubMed ID: 29241453
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota remodeling reverses aging-associated inflammation and dysregulation of systemic bile acid homeostasis in mice sex-specifically.
Ma J; Hong Y; Zheng N; Xie G; Lyu Y; Gu Y; Xi C; Chen L; Wu G; Li Y; Tao X; Zhong J; Huang Z; Wu W; Yuan L; Lin M; Lu X; Zhang W; Jia W; Sheng L; Li H
Gut Microbes; 2020 Sep; 11(5):1450-1474. PubMed ID: 32515683
[TBL] [Abstract][Full Text] [Related]
9. Bile Acid Modifications at the Microbe-Host Interface: Potential for Nutraceutical and Pharmaceutical Interventions in Host Health.
Joyce SA; Gahan CG
Annu Rev Food Sci Technol; 2016; 7():313-33. PubMed ID: 26772409
[TBL] [Abstract][Full Text] [Related]
10. The gut microbiome-bile acid axis in hepatocarcinogenesis.
Wu L; Feng J; Li J; Yu Q; Ji J; Wu J; Dai W; Guo C
Biomed Pharmacother; 2021 Jan; 133():111036. PubMed ID: 33378947
[TBL] [Abstract][Full Text] [Related]
11. Role of Microbiota-Modified Bile Acids in the Regulation of Intracellular Organelles and Neurodegenerative Diseases.
Kiriyama Y; Nochi H
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107583
[TBL] [Abstract][Full Text] [Related]
12. Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota.
Wahlström A; Kovatcheva-Datchary P; Ståhlman M; Khan MT; Bäckhed F; Marschall HU
J Lipid Res; 2017 Feb; 58(2):412-419. PubMed ID: 27956475
[TBL] [Abstract][Full Text] [Related]
13. Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review.
Talavera-Urquijo E; Beisani M; Balibrea JM; Alverdy JC
Surg Obes Relat Dis; 2020 Sep; 16(9):1361-1369. PubMed ID: 32336663
[TBL] [Abstract][Full Text] [Related]
14. Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome.
Kaska L; Sledzinski T; Chomiczewska A; Dettlaff-Pokora A; Swierczynski J
World J Gastroenterol; 2016 Oct; 22(39):8698-8719. PubMed ID: 27818587
[TBL] [Abstract][Full Text] [Related]
15. Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease.
Adams LA; Wang Z; Liddle C; Melton PE; Ariff A; Chandraratna H; Tan J; Ching H; Coulter S; de Boer B; Christophersen CT; O'Sullivan TA; Morrison M; Jeffrey GP
Liver Int; 2020 Jun; 40(6):1356-1365. PubMed ID: 32243703
[TBL] [Abstract][Full Text] [Related]
16. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.
Ikpa PT; Doktorova M; Meijsen KF; Nieuwenhuijze NDA; Verkade HJ; Jonker JW; de Jonge HR; Bijvelds MJC
Cell Mol Gastroenterol Hepatol; 2020; 9(1):47-60. PubMed ID: 31470114
[TBL] [Abstract][Full Text] [Related]
17. Physiological Role of Bile Acids Modified by the Gut Microbiome.
Kiriyama Y; Nochi H
Microorganisms; 2021 Dec; 10(1):. PubMed ID: 35056517
[TBL] [Abstract][Full Text] [Related]
18. Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels.
Keely SJ; Urso A; Ilyaskin AV; Korbmacher C; Bunnett NW; Poole DP; Carbone SE
Am J Physiol Gastrointest Liver Physiol; 2022 Feb; 322(2):G201-G222. PubMed ID: 34755536
[TBL] [Abstract][Full Text] [Related]
19. Hyodeoxycholic acid (HDCA) suppresses intestinal epithelial cell proliferation through FXR-PI3K/AKT pathway, accompanied by alteration of bile acids metabolism profiles induced by gut bacteria.
Song M; Yang Q; Zhang F; Chen L; Su H; Yang X; He H; Liu F; Zheng J; Ling M; Lai X; Zhu X; Wang L; Gao P; Shu G; Jiang Q; Wang S
FASEB J; 2020 May; 34(5):7103-7117. PubMed ID: 32246800
[TBL] [Abstract][Full Text] [Related]
20. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics.
Chen J; Thomsen M; Vitetta L
J Cell Biochem; 2019 Mar; 120(3):2713-2720. PubMed ID: 30443932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
